T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Virtus Investment Partners
VRTS
$1.12B
| $17.1M | ﹤0.01% |
89,082
-4,591
| -5% | -$821K |
|
952
Hormel Foods
HRL
$13.4B
| $17M | ﹤0.01% |
373,790
+7,032
| +2% | +$327K |
|
953
NetApp
NTAP
$39.6B
| $17M | ﹤0.01% |
283,058
-1,250
| -0.4% | -$82.9K |
|
954
Ambev
ABEV
$43.5B
| $16.9M | ﹤0.01% |
6,202,220
+473,420
| +8% | +$1.38M |
|
955
Nabors Industries
NBR
$1.33B
| $16.9M | ﹤0.01% |
108,831
-466
| -0.4% | -$69.5K |
|
956
Sana Biotechnology
SANA
$1.1B
| $16.8M | ﹤0.01% |
4,264,492
+623,989
| +17% | +$3.05M |
|
957
Lamb Weston
LW
$7.3B
| $16.7M | ﹤0.01% |
187,205
+542
| +0.3% | +$46.1K |
|
958
Ormat Technologies
ORA
$6.97B
| $16.7M | ﹤0.01% |
193,314
-16,941
| -8% | -$1.52M |
|
959
Azenta
AZTA
$1.47B
| $16.7M | ﹤0.01% |
286,606
+125,456
| +78% | +$6.42M |
|
960
Jack Henry & Associates
JKHY
$10.8B
| $16.6M | ﹤0.01% |
94,815
+322
| +0.3% | +$59.5K |
|
961
GitLab
GTLB
$7.32B
| $16.6M | ﹤0.01% |
365,394
+22,812
| +7% | +$1.03M |
|
962
Evertec
EVTC
$1.91B
| $16.6M | ﹤0.01% |
512,506
+252
| +0% | +$8.28K |
|
963
Krispy Kreme
DNUT
$573M
| $16.3M | ﹤0.01% |
1,577,112
-52,392
| -3% | -$714K |
|
964
EQT Corp
EQT
$33.8B
| $16.2M | ﹤0.01% |
479,280
-1,755
| -0.4% | -$70.4K |
|
965
Ryman Hospitality Properties
RHP
$7.82B
| $16.1M | ﹤0.01% |
196,313
-186,959
| -49% | -$16M |
|
966
Madrigal Pharmaceuticals
MDGL
$12.4B
| $16M | ﹤0.01% |
55,250
+8,629
| +19% | +$844K |
|
967
Snap-on
SNA
$21.1B
| $16M | ﹤0.01% |
70,031
+268
| +0.4% | +$60.6K |
|
968
Alector
ALEC
$228M
| $16M | ﹤0.01% |
1,728,713
-14,678
| -0.8% | -$128K |
|
|
NUVL
969
DELISTED
Nuvalent
NUVL
| $16M | ﹤0.01% |
+535,686
| New | +$14.9M |
|
970
Celanese
CE
$4.75B
| $15.9M | ﹤0.01% |
155,302
-8,596
| -5% | -$853K |
|
971
Pacira BioSciences
PCRX
$924M
| $15.6M | ﹤0.01% |
404,122
+11,048
| +3% | +$538K |
|
|
OSH
972
DELISTED
Oak Street Health, Inc.
OSH
| $15.6M | ﹤0.01% |
722,967
-39,891
| -5% | -$834K |
|
973
ACI Worldwide
ACIW
$5.33B
| $15.5M | ﹤0.01% |
674,870
+1,123
| +0.2% | +$24.2K |
|
974
Pultegroup
PHM
$24.6B
| $15.5M | ﹤0.01% |
340,774
-7,226
| -2% | -$304K |
|
975
WEX
WEX
$6.48B
| $15.4M | ﹤0.01% |
94,007
-3,019
| -3% | -$470K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.